Clinical Trials for BeyondSpring Pharmaceuticals

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: BeyondSpring Pharmaceuticals

Clinical Trials (3)

NCT05599789
Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004)
PHASE2Active, not recruiting
47 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05130827
Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)
PHASE2Active, not recruiting
17 participants
Started: Dec 21, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors7 locations
NCT02812667
Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
PHASE1Active, not recruiting
18 participants
Started: Aug 29, 2016 · Completed: Oct 24, 2025
1 condition2 sponsors1 location